1.2. Analysis.
Comparison 1 DRUG VERSUS PLACEBO, Outcome 2 Number of people failing to improve incontinence.
Number of people failing to improve incontinence | ||
---|---|---|
Study | Drug | Placebo |
Loperamide versus placebo | ||
Read 1982 # | Episodes of urgency: 7/26
Incontinence episodes: 19/26 Per cent unformed stool per week (mean, range): 40% (0%‐100%) |
Episodes of urgency: 23/26
Incontinence episodes: 24/26 Per cent unformed stool per week (mean, range): 57% (0%‐100%) (P < 0.001) |
Sun 1997 # | No improvement in stool consistency: 2/11 Per cent of days with unformed stools: 33% (loperamide oxide) |
No improvement in stool consistency: 8/11 Per cent of days with unformed stools: 66% (P < 0.02) |
Diphenoxylate + atropine versus placebo | ||
Harford 1980 # | No improvement in stool weight and frequency: 3/15 | No improvement in stool weight and frequency: 3/15 |
Phenylephrine gel versus placebo | ||
Carapeti 2000a # | No subjective improvement: 30/36 | 34/36 |
Carapeti 2000b # | No undefined 'improvement': 6/12 | 11/12 |